Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Nebraska?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Nebraska resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Nebraska-credentialed prescriber, including by telehealth, because Neb. Rev. Stat. section 38-1,143 lets any credential holder providing a telehealth service prescribe a drug they are otherwise authorized to prescribe. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed in Nebraska; the Nebraska Board of Pharmacy works with the Department of Health and Human Services Licensure Unit, which issues pharmacy licenses, including mail service pharmacy licenses for out-of-state pharmacies shipping into Nebraska.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed
Compounded GLP-1
Limited

Can a Nebraska resident get peptides by telehealth?

Neb. Rev. Stat. section 38-1,143, in the Uniform Credentialing Act, provides that a credential holder may establish a provider-patient relationship through telehealth, and that a credential holder who is providing a telehealth service to a patient may prescribe the patient a drug if authorized to prescribe under state and federal law. The Department may adopt consistent rules. Section 38-120.01 defines telehealth for the Act as medical information exchanged from one site to another, whether synchronously or asynchronously, and says it includes asynchronous services in which information is acquired and stored at one site and then forwarded to or retrieved by a credential holder for medical evaluation. The Nebraska Telehealth Act (Neb. Rev. Stat. sections 71-8501 to 71-8508) sets written information and consent rules for telehealth consultations covered by that Act. The prescriber must hold a Nebraska credential, and the standard of care still applies. Nebraska statute does not say whether a static questionnaire alone is enough. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because the statute lets the relationship be formed and a drug prescribed through telehealth, and the same Act defines telehealth to include asynchronous services. [2] [3] [4] [5]

How does the Nebraska pharmacy board treat compounding?

Compounding regulator for Nebraska
BoardNebraska Board of Pharmacy (licensing through the Department of Health and Human Services, Division of Public Health, Licensure Unit)
Eligible substancesFollows the federal 503A framework

The Nebraska Board of Pharmacy advises the Department of Health and Human Services, which credentials pharmacists under the Pharmacy Practice Act (Neb. Rev. Stat. sections 38-2801 and following) and licenses pharmacies. Under Neb. Rev. Stat. section 71-2407, part of the Mail Service Pharmacy Licensure Act, any person operating a mail service pharmacy outside Nebraska must obtain a Nebraska mail service pharmacy license before shipping, mailing, or delivering dispensed prescription drugs into the state, must hold a valid pharmacy license in its home state, and must employ full time at least one pharmacist holding a Nebraska license who is responsible for compliance. Compounding standards are set by statute: Neb. Rev. Stat. section 38-2867.01 requires anyone authorized to compound to follow USP chapters 795 and 797 as they existed on January 1, 2023, and bars compounding a drug that is essentially a copy of an approved drug unless the Board determines there is a drug shortage or the patient is allergic to the approved drug, and bars compounding any drug FDA or the Board has identified as one that may not be compounded. Nebraska has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [6] [7] [8] [9] [10]

Can you get compounded GLP-1s in Nebraska?

Regulatory: Compounded GLP-1 limited

Nebraska patients using telehealth GLP-1 programs should confirm that the shipping pharmacy holds a Nebraska mail service pharmacy license in the DHHS license lookup. [9] [13]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Nebraska?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Nebraska

What you'll actually find in Nebraska, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [17] [18] [19]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]

What Nebraska has done

PeptideAgent has not found a board or legislative action on peptides in Nebraska.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [22] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Nebraska. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [2] [3] [4] [5] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Nebraska Board of Pharmacy (licensing through the Department of Health and Human Services, Division of Public Health, Licensure Unit); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [21]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [20]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [25] [26]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [21] [27] [28]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [19] [28] [29]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [20] [30] [31] [32] [33] [34]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [20]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [21]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [19]
  • Pharmacy: Is this made for me on a prescription written in my name? [29]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [19] [28]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [19]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Nebraska?

The Nebraska Pharmacy Practice Act limits dispensing of prescription drugs to licensed pharmacies and practitioners, so sellers of "research use only" injectable peptides to Nebraska consumers are not lawful dispensers in the state. [6] [14]

Peptide-specific notes for Nebraska

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Nebraska through telehealth?

Yes. Neb. Rev. Stat. section 38-1,143 lets a Nebraska credential holder who is providing telehealth prescribe any drug they are authorized to prescribe, and semaglutide and tirzepatide are not controlled substances. [2]

Who licenses pharmacies in Nebraska?

The Department of Health and Human Services Licensure Unit issues pharmacist credentials and pharmacy licenses, with the Board of Pharmacy advising on standards and discipline. Use the DHHS license lookup to verify a pharmacy. [1] [6]

Can an out-of-state pharmacy ship compounded peptides to me in Nebraska?

Only if it holds a Nebraska mail service pharmacy license from DHHS. If the pharmacy does not appear in the Nebraska license lookup, the shipment is not lawful in Nebraska. [7] [9]

Can a Nebraska pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Nebraska has no state bulks list; peptide eligibility follows the federal 503A framework. [10] [11] [12] [15] [16]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Nebraska DHHS Licensure Unit: pharmacist and Board of Pharmacy information
  2. [2]Neb. Rev. Stat. section 38-1,143, Telehealth; provider-patient relationship; prescription authority; applicability of section
  3. [3]Neb. Rev. Stat. section 38-120.01, Telehealth, defined
  4. [4]Neb. Rev. Stat. section 38-105, Definitions, where found
  5. [5]Nebraska Telehealth Act, Neb. Rev. Stat. sections 71-8501 to 71-8508 (DHHS compilation)
  6. [6]Nebraska statutes relating to the Pharmacy Practice Act (DHHS compilation)
  7. [7]Neb. Rev. Stat. section 71-2407, Mail service pharmacy license; requirements; fee
  8. [8]Neb. Rev. Stat. section 38-2867.01, Authority to compound; standards; labeling; prohibited acts
  9. [9]Nebraska DHHS: mail service pharmacy initial license application
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Nebraska?. https://peptideagent.ai/legal/nebraska
HTML link
<a href="https://peptideagent.ai/legal/nebraska">Are peptides legal in Nebraska?</a>, PeptideAgent, updated October 28, 2026.